GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AXSM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Is Axsome Therapeutics stock still a buy after falling -5.72% on Thursday?
(Updated on Apr 18, 2024)

Sell candidate since Mar 28, 2024 Loss -17.64% PDF

The Axsome Therapeutics stock price fell by -5.72% on the last day (Thursday, 18th Apr 2024) from $69.71 to $65.72. During the last trading day the stock fluctuated 6.81% from a day low at $65.61 to a day high of $70.08. The price has been going up and down for this period, and there has been a -8.94% loss for the last 2 weeks. Volume has increased on the last day by 449 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 834 thousand shares were bought and sold for approximately $54.82 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.43% during the next 3 months and, with a 90% probability hold a price between $43.44 and $58.11 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AXSM Signals & Forecast

There are few to no technical positive signals at the moment. The Axsome Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $69.19 and $74.10. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, March 21, 2024, and so far it has fallen -18.72%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Axsome Therapeutics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.47 between high and low, or 6.81%. For the last week, the stock has had daily average volatility of 4.73%.

Axsome Therapeutics is oversold on RSI14 (14). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AXSM) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Axsome Therapeutics to open at $67.13, and during the day (based on 14 day Average True Range), to move between $62.49 and $68.95, which gives a possible trading interval of +/-$3.23 (+/-4.91%) up or down from last closing price. If Axsome Therapeutics takes out the full calculated possible swing range there will be an estimated 9.82% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $75.54, some $9.82 (14.94%) from the current price of $65.72, our system finds the risk reward not very attractive.

Is Axsome Therapeutics stock A Buy?

Axsome Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.862 Sell Candidate Unchanged

Predicted Opening Price for Axsome Therapeutics of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$67.13 ( 2.15%) $65.72

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AXSM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 71.61 8.96 %
R2 69.90 6.36 %
R1 68.84 4.75 %
Current price: 65.72
Support S1 65.43 -0.446 %
S2 64.37 -2.05 %
S3 62.66 -4.65 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 82.11 24.94 %
R2 81.14 23.46 %
R1 75.54 14.94 %
Current price 65.72
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Axsome Therapeutics Stock and on which exchange is it traded?
The symbol for Axsome Therapeutics is AXSM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Axsome Therapeutics Stock?
Axsome Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Axsome Therapeutics Stock?
Axsome Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Axsome Therapeutics Stock.

What's the current price of Axsome Therapeutics Stock?
As of the end of day on the 2024-04-18, the price of an Axsome Therapeutics (AXSM) share was $65.72.

What is the 52-week high and low for Axsome Therapeutics Stock?
The 52-week high for Axsome Therapeutics Stock is $98.40 and the 52-week low is $55.03.

What is the market capitalization of Axsome Therapeutics Stock?
As of the 2024-04-18, the market capitalization of Axsome Therapeutics is 3.302B.

When is the next earnings date for Axsome Therapeutics?
The upcoming earnings date for Axsome Therapeutics is May 06, 2024.
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT